Drug Interaction Study to Asses Multiple Doses of ZD4054 (Zibotentan)
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to to assess the effect of multiple oral doses of ZD4054
(Zibotentan) on the pharmacokinetics of a CYP450 3A Probe (midazolam) in healthy male
subjects.